Inventor · disambiguated record
Nicholas Robert Perl
Also filed as: PERL NICHOLAS · PERL NICHOLAS ROBERT
14 granted patents·17 pending applications·112 citations·filing 2011–2024
92Inventor score
Files withIRONWOOD PHARMACEUTICALS INC17CYCLERION THERAPEUTICS INC9KIM CHARLES2TISENTO THERAPEUTICS INC2NAKAI TAKASHI1
Top patents by PatentIndex Score
31 records- 0194US9586937B2sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2016·Granted Mar 7, 2017·13 cites·2 claims
- 0293US9481689B2sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2014·Granted Nov 1, 2016·16 cites·2 claims
- 0392US8748442B2sGC stimulatorsKIM CHARLES·Filed 2011·Granted Jun 10, 2014·22 cites·79 claims
- 0491US10183021B2sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2016·Granted Jan 22, 2019·8 cites·9 claims
- 0591US9139564B22-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2012·Granted Sep 22, 2015·15 cites·6 claims
- 0690US10639308B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2018·Granted May 5, 2020·3 cites·31 claims
- 0790US9061030B2sGC stimulatorsKIM CHARLES·Filed 2011·Granted Jun 23, 2015·19 cites·44 claims
- 0887US10517874B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Dec 31, 2019·4 cites·17 claims
- 0986US2025243177A1sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1080US10047095B2sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2015·Granted Aug 14, 2018·4 cites·26 claims
- 1179US2025108040A1TREATMENT OF CNS DISEASES WITH sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1278US9487508B2SGC stimulatorsNAKAI TAKASHI·Filed 2013·Granted Nov 8, 2016·4 cites·24 claims
- 1377US11690828B2Treatment of CNS diseases with sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Jul 4, 2023·2 cites·2 claims
- 1477US10844064B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2015·Granted Nov 24, 2020·2 cites·9 claims
- 1577US2023106002A1sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1676US2023381153A1TREATMENT OF CNS DISEASES WITH sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1771US11207323B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2020·Granted Dec 28, 2021·0 cites·4 claims
- 1870US2021221793A1Pyrazole derivatives as sgc stimulatorsCYCLERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1963US2019345130A1Sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2061US2021214364A1sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2161US2014323448A1sGC STIMULATORSIRONWOOD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2260US2019284168A1Pyrazole derivaties as sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2358US10189809B2SGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2017·Granted Jan 29, 2019·0 cites·23 claims
- 2458US2019031641A1Pyrazole derivatives as sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2553US2016311826A1Sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2651US2017291889A1Pyrazole derivatives as sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2749US2017112845A1sGC STIMULATORSIRONWOOD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2846US2015250795A1sGC STIMULATORSIRONWOOD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2945US2017065586A1Sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3042US2015342954A12-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3135US2017298055A1sGC STIMULATORSIRONWOOD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas Robert Perl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →